Is stopping secondary prophylaxis safe in HIV‐positive talaromycosis patients? Experience from Myanmar-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is stopping secondary prophylaxis safe in HIV‐positive talaromycosis patients? Experience from Myanmar

Published:2020-08 Issue:10 Volume:21 Page:671-673
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med.

Author:

Tun N¹²^ORCID,Mclean A¹²,Deed X¹,Hlaing M¹,Aung Y¹,Wilkins E³,Ashley E²⁴,Smithuis F¹²⁴

Affiliation:

1. Medical Action Myanmar Yangon Myanmar

2. Myanmar Oxford Clinical Research Unit Yangon Myanmar

3. North Manchester, Infectious Diseases Crumpsall Manchester Manchester UK

4. Centre for Tropical Medicine and Global Health Oxford Oxford University Oxfordshire UK

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.12921

Reference8 articles.

1. SupparatpinyoK KhamwanC BaosoungVet al.DisseminatedPenicillium marneffeiinfection in southeast Asia. 7912350 [uid].

2. Amphotericin B and Itraconazole for Treatment of DisseminatedPenicillium marneffeiInfection in Human Immunodeficiency Virus–Infected Patients

3. An efficacy study of itraconazole in the treatment of Penicillium marneffei infection;Supparatpinyo K;J Med Assoc Thai,1992

4. A Controlled Trial of Itraconazole to Prevent Relapse ofPenicillium marneffeiInfection in Patients Infected with the Human Immunodeficiency Virus

5. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease;Journal of Fungi;2023-06-06

2. Chinese Guidelines for the Diagnosis and Treatment of HIV/AIDS (2021 Edition);Infectious Diseases & Immunity;2022-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3